Bill > LD1499

This bill establishes the Maine Prescription Drug Affordability Board, a 5-member board with expertise in healthcare economics or clinical medicine, appointed by the President of the Senate, Speaker of the House, and Governor. The board is tasked with determining annual spending targets for prescription drugs purchased by public payors (state, county, or municipal government health plans) based on the Consumer Price Index and pharmacy savings. The board can also recommend methods for public payors to meet these spending targets, such as negotiating drug rebates, changing drug formularies, bulk purchasing, and collaborating with other states. The board must report its recommendations and progress to the legislature annually. The bill also allows the Maine Health Data Organization to share data with the board.

Health and Social Services

http://legislature.maine.gov/legis/bills/display_ps.asp?LD=1499&snum=129